lipoxin a4 has been researched along with iloprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Romano, M; Serhan, CN | 1 |
| Asadullah, K; Bauman, J; Colgan, SP; Fierro, IM; Giesen, C; Guilford, W; Parkinson, JF; Perez, HD; Schottelius, AJ | 1 |
| Bouchier-Hayes, D; Condron, C; Cunningham, AJ; Gang, C; Scully, M | 1 |
3 other study(ies) available for lipoxin a4 and iloprost
| Article | Year |
|---|---|
Lipoxin generation by permeabilized human platelets.
Topics: Blood Platelets; Cell Membrane Permeability; Eicosanoids; Humans; Hydroxyeicosatetraenoic Acids; Iloprost; In Vitro Techniques; Isomerism; Kinetics; Leukotriene A4; Leukotrienes; Lipoxins | 1992 |
An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcimycin; Cell Movement; Chemotaxis, Leukocyte; Croton Oil; Disease Models, Animal; Diterpenes; Female; Guinea Pigs; Humans; Hydroxyeicosatetraenoic Acids; Hypersensitivity, Delayed; Iloprost; Inflammation; Leukotriene B4; Lipoxins; Mice; Phthalic Anhydrides; Skin; Terpenes | 2002 |
Protective role of cyclooxygenase (COX)-2 in experimental lung injury: evidence of a lipoxin A4-mediated effect.
Topics: Animals; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Iloprost; Lipoxins; Lung; Lung Injury; Male; Protective Agents; Pyrazoles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sulfonamides | 2012 |